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TABLE ONE: ASSOCIATED SIGNS
NEURO SIGNS (Tables 2 & 3) Dermatologic Hepatic/Splenic Abnormality
Mental Retardation Dysmorphic features Endocrine Abnormality
Dementia Abnormal Body Size Genitourinary Abnormality
Movement Disorder Visual Signs Skeletal/Connective Tissue Abnormality
Neuropathy Hearing Loss Hematologic Disorder
Spasticity Speech Abnormality Vascular Pathology
Seizures Cardiac Abnormality None
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BACKGROUND: Neuropsychiatrists are often called upon to evaluate 
psychotic individuals for possible neurological or neurodevelopmental 
etiologies after acquired neurological and other medical disorders 
have been ruled out.   A large number of relatively rare congenital 
neuropsychiatric conditions that include psychosis have been described. 
Clear guidance on the neuropsychiatric evaluation and differential 
diagnosis of these conditions is difﬁcult to ﬁnd in standard textbooks.
OBJECTIVE: To address  this  dearth of information we set out to 
concisely describe the neurodevelopmental disorders in the differential 
diagnosis of psychosis, their neurodiagnostic and laboratory evaluations, 
and relative prevalence.
CONCLUSION: As consultants frequently called 
upon to evaluate atypical presentations of psychosis, 
neuropsychiatrists should be aware of congenital 
disorders that can present with psychosis, however 
rarely.  We  recommend a differential diagnostic 
approach based on estimated prevalence of the 
disorders and their most prominent associated 
neuropsychiatric features. 
RESULTS: We identiﬁed  61 congenital disorders that 
may present from childhood through middle age and 
include psychosis. 
METHODS: A literature search was conducted for disorders that 
may present with psychosis, utilizing PubMed and Ovid, with search 
terms including psychosis, metabolic, genetic, congenital and 
neurodevelopmental disorders.  All disorders described in case reports 
or case series and literature reviews, including their references, were 
initially included.    Epidemiological and diagnostic information was 
gathered via textbooks, OMIM1, GENETests2, and orphanet3. 
Exclusion Criteria: 1. Acquired (non-heritable/non-congenital)    
   disorders
 2. Fewer than 3 cases reported with psychosis
 3. Poorly described psychosis
Analysis:  Disorders were categorized as follows:
1. By the presence of one or more of 20 associated signs (Table One)    
 Disorders having major associated neurological signs are presented  
 in Tables Two and Three along with principal diagnostic tests
DISCUSSION:
TABLE TWO: “DOORWAY DIAGNOSES”‡
‡ “Doorway Diagnoses” can be recognized by their unique phenotypic features
2. By unique phenotypic features (“Doorway Diagnoses”—Table Two)
3. By prevalence (> 1/10,000; 1/10,000-1/50,000; <1/50,000)
TABLE THREE: DIAGNOSES WITH LESS OBVIOUS PHENOTYPES
CODE DIAGNOSIS WORKUP
Autism N/A
D S Z Cerebrotendinous Xanthomatosis B: · cholestanol
Kartagener Syndrome T: mucosal biopsy
Z Tuberous Sclerosis X: MRI & CT calciﬁed nodules
M Homocysteinuria B/U: · methionine & homocysteine
M MR with Psychosis, Pyramidal Signs, 
and Macroorchidism (PPX-M)
G: mutation analysis
Z Neurocutaneous Melanosis X: MRI melanin deposits
M Z Succinic Semialdehyde 
Dehydrogenase (SSADH) Deﬁciency
U: · γ-hydroxybutyric acid
N Acute Intermittent Porphyria U: · porphobilinogen & δ−aminolevulinic acid
Asperger’s NA
Gilbert Syndrome B: ﬂuctuating · indirect bilirubin
Glucose-6-Phosphate 
Dehydrogenase Deﬁciency
B: RBC G6PD test
D M Huntington Disease G: CAG repeats
Neuroﬁbromatosis, Type 1 NA
Velo-Cardio-Facial Syndrome G: FISH
XXX Karyotype G: XXX
D N Z Adrenoleukodystrophy B: · VLCFA
N Fabry Disease B: ‚ α-galactosidase A
D M N S Metachromatic Leukodystrophy B: ‚ arylsulfatase A
N Porphyria Variegata U: · porphobilinogen & δ−aminolevulinic acid
D M Wilson Disease B: ‚ ceruloplasmin & · copper
XYY Karyotype G: XYY
Albright Hereditary Osteodystrophy B: ‚calcium; · phosphorus & PTH;  
Ellsworth-Howard test
N Chester Porphyria U: · porphobilinogen & δ−aminolevulinic acid
Darier Disease T: skin biopsy 
D M Z Dentatorubral-Pallidolysian Atrophy 
(DRPLA)
G: CAG repeats
D M Z Fahr Disease X: BG calciﬁcation
Familial Hemiplegic Migraine G: CACNA1A gene mutation
Gaucher Disease, Type 1 B: ‚ β-glucosidase
M Z Gaucher Disease, Type 3 B: ‚ β-glucosidase
D Gerstmann-Sträussler-Scheinker G: PRNP mutation
N Hereditary Coproporphyria U/S: · coproporphyrin 
D N S Hereditary Spastic Paraparesis G: SPG4 gene mutation
D M Z Kuf Disease T: brain, muscle, or skin biopsy
D M Late Onset Tay-Sachs B: ‚ hexosaminidase A activity
D M Z Mitochondrial Encephalopathy,  
Lactic Acidosis, and Stroke-Like 
Episodes (MELAS)
B: · lactate, ‚ pyruvate
M Myoclonus-Dystonia G: SGCE gene mutation
D M Z Nasu-Hakola X: polycystic osseous lesions
D M Z Neimann-Pick Disease Type C T: skin biopsy (ﬁbroblasts)
D M N Z Neuroacanthocytosis B: acanthocytosis; X: MRI caudate nuclei atrophy
D M Neurodegeneration with Brain Iron 
Accumulation (NBIA)
X: MRI T2 central pallidal hyperintensity with  
hypointense surround (‘eye of the tiger’ sign)
D M N Olivopontocerebellar Atrophy X: MRI & CT olivopontocerebellar atrophy
D M S Pelizeus-Merzbacher Disease X: MRI white matter disease
M S Spinocerebellar Degenerations G: CAG repeats
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CODE DIAGNOSIS FEATURE WORKUP
D Down Syndrome dysmorphic, short G:  trisomy 21
Fragile X Syndrome dysmorphic G: CGG repeats
SZ Phenylketonuria blond, blue-eyed, dry skin, musty odor B: · phenylalanine
Cofﬁn-Lowry Syndrome dysmorphic, short X: XR distal phalangeal tufting
Prader Willi Syndrome dysmorphic, short, obese G: DNA methylation analysis
S Laurence-Moon/Biedl-Bardet dysmorphic, short, obese NA
Lujan-Fryns Syndrome dysmorphic, marfanoid NA
Norrie Disease hearing and vision impairment G: mutation analysis
Wolfram Syndrome hearing and vision impairment NA
Klinefelter Syndrome XXY tall, long arms G:  XXY
Marfan Syndrome dysmorphic, marfanoid NA
Oculocutaneous Albinism hypopigmented skin and hair, blue to 
yellow-brown irides
G: mutation analysis
Turner Syndrome dysmorphic, short, obese, webbed neck G:  XO
Z Sturge-Weber Syndrome port-wine stain X: MRI/CT angiomatosis/gyral 
calciﬁcations (railroad track sign)
M Tourette Syndrome motor & vocal tics NA
Usher Syndrome hearing and vision impairment O: ERG & ENG
Werner Syndrome short, stocky, premature aging, beaked 
nose
NA
WORKUP CODES
B = Bloodwork
G = Genetic test/ karyotype
O = Other
S = Stool
T = Tissue biopsy
U = Urine
X = Radiology
Case-report based research such as this is limited 
by difﬁculty in determining whether a reported re-
lationship is coincidental or causal.  
The cost of doing an exhaustive laboratory eval-
uation of all possible disorders that could result 
in psychosis would be astronomical.  A coherent 
neuropsychiatric approach, such as the one pre-
sented here, increases cost savings by providing 
a probability-guided, examination-based approach 
to focus the workup.
Accurate neuropsychiatric diagnosis guides 
genetic counseling and treatment planning.
Studying neuropsychiatric disorders of known eti-
ology that include psychosis will ultimately lead to 
research aimed at understanding the etiology of 
psychotic symptoms in Axis I disorders.
1.
2.
3.
4.
44 disorders (72%) have prominent associated 
neurological features that facilitate differential 
diagnosis.  
17 disorders have readily recognizable unique 
phenotypes.  
44 disorders may present without mental 
retardation.  
52 disorders (85%) have characteristic laboratory 
features. 
52 have known genetic loci and 3 disorders have 
loci yet unkown.  
5 disorders were due to chromosomal 
nondisjunction.
•
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NEURO CODES
D = Dementia
M = Movement disorder
N = Neuropathy
S = Spasticity
Z = Seizures
Disorder’s color indicates
its prevalence.
